| Literature DB >> 29524951 |
Fatemeh Jahanbakhsh1, Fahimeh Bagheri Amiri2, Abbas Sedaghat3,4, Noushin Fahimfar5,6, Ehsan Mostafavi7,6.
Abstract
BACKGROUND: This study investigated the prevalence for hepatitis A virus (HAV), hepatitis E virus (HEV), herpes simplex virus type 2 (HSV2) and syphilis among homeless in the city of Tehran.Entities:
Keywords: Hepatitis A Virus (HAV); Hepatitis E Virus (HEV); Herpes Simplex Virus Type 2 (HSV2); Homeless; Iran; Syphilis
Mesh:
Substances:
Year: 2018 PMID: 29524951 PMCID: PMC5890067 DOI: 10.15171/ijhpm.2017.74
Source DB: PubMed Journal: Int J Health Policy Manag ISSN: 2322-5939
Univariate Analysis of Factors Associated With the Prevalence of HAV, HEV, HSV2 and Syphilis on Homeless People in Tehran, 2012
|
|
|
|
|
|
|
|
|
|
|
| Age* | More than 42 year | 261 (1.15) | 0.61 (0.02-8.07) | 258 (98.06) | 5.44 (5.05-14.39) | 265 (35.47) | 3.27 (2.16-4.96) | 260 (16.54) | 1.04 (0.65-1.64) |
| Less than 42 years | 269 (0.00) | 268 (90.30) | 285 (14.39) | 274 (16.06) | |||||
| Gender | Female | 78 (0.00) | 0.61 (0.02-8.07) | 78 (84.62) | 4.22 (1.96-9.09) | 484 (25.62) | 1.72 (0.92-3.23) | 468 (15.60) | 0.66 (0.37-1.20) |
| Male | 464 (0.64) | 460 (95.87) | 78 (16.17) | 78 (21.79) | |||||
| Educational level | Illiterate | 65 (0.00) | - | 66 (100.00) | - | 67 (40.30) | Reference | 66 (16.67) | Reference |
| Literate | 28 (0.00) | - | 28 (100.00) | - | 28 (46.43) | 1.28 (0.53-3.12) | 28 (21.43) | 1.36 (0.45-4.14) | |
| Primary school | 105 (1.90) | - | 103 (95.15) | - | 110 (30.91) | 0.66 (0.35-1.25) | 105 (19.05) | 1.18 (0.52-2.65) | |
| Secondary school | 142 (0.00) | - | 143 (95.10) | - | 149 (18.12) | 0.33 (0.17-0.62) | 146 (14.38) | 0.84 (0.38-1.86) | |
| High school | 143 (0.70) | - | 139 (90.45) | - | 143 (16.78) | 0.30 (0.16-0.58) | 139 (15.11) | 0.89 (0.40-1.97) | |
| Academic level | 44 (0.00) | - | 43 (86.05) | - | 48 (16.67) | 0.30 (0.12-0.73) | 46 (15.22) | 0.90 (0.32-2.52) | |
| Duration of being Homelessa | More than 24 months | 233 (0.43) | 0.61 (0.02-8.07) | 232 (93.66) | 0.99 (0.48-2.07) | 240 (25.83) | 1.16 (0.78-1.72) | 232 (15.94) | 0.91 (0.57-1.45) |
| Less than 24 months | 285 (0.70) | 282 (93.97) | 298 (23.15) | 290 (17.24) | |||||
| History of Drug use | Yes | 412 (0.73) | 4.88 (0.42-163.20) | 409 (94.13) | 1.05 (0.44-2.50) | 433 (23.56) | 1.26 (0.81-1.98) | 417 (15.35) | 1.38 (0.83-2.30) |
| No | 126 (0.00) | 125 (94.40) | 125 (28.00) | 125 (20.00) | |||||
| Drug use (currently) | Yes | 180 (0.56) | 0.64 (0.02-8.51) | 175 (92.00) | 1.95 (0.84-4.50) | 200 (24.00) | 0.96 (0.61-1.49) | 185 (18.92) | 0.61 (0.36-1.05) |
| No | 232 (0.86) | 234 (95.73) | 233 (23.18) | 232 (12.50) | |||||
|
| |||||||||
| Hashish | Yes | 11 (0.00) | 25.11 (0.51-1274) | 10 (100.00) | 1.43 (0.17-42.76) | 11 (45.45) | 2.83 (0.82-9.73) | 10 (10.00) | 0.46 (0.06-3.76) |
| No | 169 (0.59) | 165 (91.51) | 189 (24.34) | 175 (19.42) | |||||
| Kerackb | Yes | 41 (0.00) | 5.54 (0.11-266.30) | 40 (90.00) | 0.72 (0.21-2.43) | 53 (22.64) | 0.90 (0.43-1.90) | 43 (16.28) | 0.79 (0.32-1.97) |
| No | 139 (0.72) | 135 (92.59) | 147 (24.29) | 142 (19.72) | |||||
| Heroin | Yes | 60 (0.00) | 3.27 (0.07-156.60) | 57 (92.98) | 1.23 (0.37-4.10) | 67 (28.36) | 1.42 (0.73-2.78) | 60 (18.33) | 0.95 (0.43-2.08) |
| No | 120 (0.83) | 118 (93.22) | 133 (21.80) | 125 (19.20) | |||||
| Methamphetamine | Yes | 80 (1.25) | 2.04 (0.04-97.87) | 75 (92.00) | 1.01 (0.34-3.05) | 90 (20.00) | 0.66 (0.34-1.28) | 80 (22.50) | 1.60 (0.76-3.37) |
| No | 99 (0.00) | 99 (91.92) | 109 (27.52) | 104 (15.38) | |||||
| Opium | Yes | 60 (0.00) | 0.83 (0.02-36.63) | 57 (94.74) | 1.85 (0.50-6.91) | 70 (22.86) | 0.91 (0.46-1.80) | 60 (13.33) | 0.56 (0.24-1.32) |
| No | 120 (0.83) | 118 (90.68) | 130 (24.42) | 125 (21.60) | |||||
| Others | Yes | 11 (0.00) | 0.11 (0.01-5.48) | 10 (90.00) | 0.77 (0.09-6.56) | 12 (41.67) | 2.41 (0.73-7.97) | 11 (90.90) | 0.41 (0.05-3.33) |
| No | 169 (0.59) | 165 (92.12) | 188 (22.87) | 174 (19.54) | |||||
| Injecting drugs | Yes | 303 (0.33) | 0.54 (0.01-25.60) | 101 (93.07) | 0.87 (0.35-2.14) | 113 (25.66) | 1.10 (0.67-1.81) | 103 (15.53) | 0.89 (0.48-1.64) |
| No | 99 (0.00) | 297 (93.94) | 310 (23.87) | 304 (17.11) | |||||
| Sharing needle | Yes | 49 (0.00) | - | 51 (92.16) | 0.76 (0.14-3.91) | 58 (29.31) | 1.45 (0.62-3.41) | 52 (13.46) | 0.71 (0.24-2.08) |
| No | 49 (0.00) | 49 (93.88) | 54 (22.22) | 50 (18.00) | |||||
| Age at the start of injecting drug | 43 (0.00) | - | 44 (95.45) | 1.79 (0.31-10.26) | 49 (26.53) | 1.04 (0.44-2.46) | 44 (15.91) | 1.06 (0.35-3.21) | |
| 50 (0.00) | 51 (92.16) | 58 (25.86) | 53 (15.09) | ||||||
| History of Incarceration | Never | 273 (1.09) | - | 271 (93.36) | Reference | 281 (25.53) | Reference | 273 (17.94) | Reference |
| More than 10 years ago | 64 (0.00) | - | 62 (96.77) | 2.13 (0.48-9.45) | 65 (24.61) | 0.97 (0.52-1.81) | 62 (17.74) | 0.99 (0.48-2.03) | |
| Recent 10 years | 194 (0.00) | - | 194 (94.33) | 1.18 (0.55-2.57) | 205 (23.41) | 0.90 (0.59-1.38) | 200 (14.00) | 0.74 (0.45-1.23) | |
| Duration of Incarceration (in last 10 years)a | Upper than 11 months | 95 (0.00) | - | 95 (93.68) | 0.79 (0.24-2.71) | 101 (28.71) | 1.88 (0.97-3.66) | 98 (13.27) | 0.88 (0.39-1.95) |
| Lower than 11 months | 98 (0.00) | 98 (94.90) | 102 (17.65) | 101 (14.85) | |||||
| History of having sex | Yes | 429 (0.47) | 0.48 (0.04-5.37) | 424 (93.63) | 0.58 (0.20-1.70) | 441 (24.72) | 1.09 (0.67-1.77) | 429 (16.62) | 0.77 (0.45-1.32) |
| No | 104 (0.96) | 105 (96.19) | 112 (23.21) | 108 (19.44) | |||||
| Condom use at last sexual encounter | Yes | 145 (0.00) | 1.28 (0.04-19.87) | 141 (90.07) | 0.44 (0.20-0.96) | 147 (22.45) | 0.82 (0.52-1.31) | 144 (12.50) | 0.68 (0.38-1.22) |
| No | 282 (0.71) | 281 (95.37) | 292 (26.03) | 283 (17.31) | |||||
| Sex work (female) | Yes | 14 (0.00) | - | 14 (78.57) | 2.14 (0.46-9.90) | 14 (7.14) | 3.90 (0.46-32.94) | 14 (14.28) | 1.26 (0.24-6.61) |
| No | 52 (0.00) | 53 (88.68) | 52 (23.08) | 52 (17.31) | |||||
| Men who have sex with men | Yes | 32 (0.00) | 6.64 (0.20-104.60) | 32 (87.50) | 3.34 (1.02-10.93) | 33 (24.24) | 1.06 (0.46-2.44) | 32 (18.75) | 0.72 (0.28-1.85) |
| No | 321 (0.62) | 317 (95.90) | 332 (25.30) | 322 (14.29) | |||||
Abbreviations: HAV, hepatitis A virus; HEV, hepatitis E virus; HSV2, herpes simplex virus type 2.
a Median of the variable is used for analysis; b A purified and potent form of heroin (not to be mistaken with crack cocaine).